THE 5-SECOND TRICK FOR MBL77

Not all people with CLL demand therapy. Despite all current advances, the iwCLL however recommends watchful observation for sufferers with asymptomatic disease.86 This suggestion is based on not less than two randomized trials evaluating observation to possibly chlorambucil monotherapy or fludarabine, cyclophosphamide and rituximab (FCR).103,104 Bo